HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats.

Abstract
Mechanisms by which endothelin (ET)-1 mediates chronic pulmonary hypertension remain incompletely understood. Although activation of the ET type A (ET(A)) receptor causes vasoconstriction, stimulation of ET type B (ET(B)) receptors can elicit vasodilation or vasoconstriction. We hypothesized that the ET(B) receptor attenuates the development of hypoxic pulmonary hypertension and studied a genetic rat model of ET(B) receptor deficiency (transgenic sl/sl). After 3 wk of severe hypoxia, the transgenic sl/sl pulmonary vasculature lacked expression of mRNA for the ET(B) receptor and developed exaggerated pulmonary hypertension that was characterized by elevated pulmonary arterial pressure, diminished cardiac output, and increased total pulmonary resistance. Plasma ET-1 was fivefold higher in transgenic sl/sl rats than in transgenic controls. Although mRNA for prepro-ET-1 was not different, mRNA for ET-converting enzyme-1 was higher in transgenic sl/sl than in transgenic control lungs. Hypertensive lungs of sl/sl rats also produced less nitric oxide metabolites and 6-ketoprostaglandin F(1alpha), a metabolite of prostacyclin, than transgenic controls. These findings suggest that the ET(B) receptor plays a protective role in the pulmonary hypertensive response to chronic hypoxia.
AuthorsD Dunbar Ivy, Masashi Yanagisawa, Cheryl E Gariepy, Sarah A Gebb, Kelley L Colvin, Ivan F McMurtry
JournalAmerican journal of physiology. Lung cellular and molecular physiology (Am J Physiol Lung Cell Mol Physiol) Vol. 282 Issue 4 Pg. L703-12 (Apr 2002) ISSN: 1040-0605 [Print] United States
PMID11880295 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Endothelin-1
  • Endothelins
  • Protein Precursors
  • RNA, Messenger
  • Receptor, Endothelin B
  • Receptors, Endothelin
  • Nitric Oxide
  • 6-Ketoprostaglandin F1 alpha
  • Cytochrome P-450 Enzyme System
  • Epoprostenol
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Intramolecular Oxidoreductases
  • prostacyclin synthetase
Topics
  • 6-Ketoprostaglandin F1 alpha (biosynthesis)
  • Animals
  • Animals, Genetically Modified
  • Anoxia (pathology, physiopathology)
  • Blotting, Northern
  • Cytochrome P-450 Enzyme System (analysis)
  • Endothelin-1 (blood)
  • Endothelins (genetics)
  • Epoprostenol (metabolism)
  • Female
  • Gene Expression (physiology)
  • Hypertension, Pulmonary (pathology, physiopathology)
  • In Situ Hybridization
  • Intramolecular Oxidoreductases (analysis)
  • Lung (enzymology, pathology, physiopathology)
  • Male
  • Nitric Oxide (biosynthesis)
  • Nitric Oxide Synthase (analysis)
  • Nitric Oxide Synthase Type III
  • Protein Precursors (genetics)
  • Pulmonary Circulation (physiology)
  • RNA, Messenger (analysis)
  • Rats
  • Receptor, Endothelin B
  • Receptors, Endothelin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: